Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
Between the very common and the very rare – An opinionated take on NEJM highlights for October 2017
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for September 2017
By
Marc Herant
NEJM
Read more
Price, costs, value, and rules: An opinionated take on NEJM highlights for August 2017
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for July 2017
By
Marc Herant
NEJM
Read more
June was negative-to-ambiguous: an opinionated take on NEJM highlights for June 2017
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for May 2017
By
Marc Herant
NEJM
Read more
April was a light month: an opinionated take on NEJM highlights for April 2017
By
Marc Herant
NEJM
Read more
A population health approach to value-based drug pricing
By
Marc Herant
Biopharma
,
Payers
Read more
Regeneration and mitigation: an opinionated take on NEJM highlights for March 2017
By
Marc Herant
NEJM
Read more
It’s in the blood: an opinionated take on NEJM highlights for February 2017
By
Marc Herant
NEJM
Read more
Keeping the pipes clean and the wires intact: an opinionated take on NEJM highlights for January 2017
By
Marc Herant
NEJM
Read more
A strong close to a banner year for progress against cancer: an opinionated take on NEJM highlights for December 2016
By
Marc Herant
NEJM
Read more
We may figure out cancer before we figure out the healthcare system: an opinionated take on NEJM highlights for November 2016
By
Marc Herant
NEJM
Read more
An ad page in the NEJM and the future of cancer care
By
Marc Herant
Providers
,
NEJM
Read more
An opinionated take on NEJM highlights for October 2016
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for September 2016
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for August 2016: cleanliness is not next to healthiness, testing before thinking, a long slog for precision medicine
By
Marc Herant
NEJM
Read more
NEJM Highlights for July 2016: Bayesians vs. frequentists, PCPs vs. specialists, SGLT-2 vs. GFR
By
Marc Herant
NEJM
Read more
NEJM Highlights for June 2016: Improving care delivery is just plain #%^*! hard
By
Marc Herant
NEJM
Read more
The many ways in which decreasing volatility in individual health care utilization is valuable
